Search results
Results from the WOW.Com Content Network
Osazone formation was developed by Emil Fischer, [3] who used the reaction as a test to identify monosaccharides. The formation of a pair of hydrazone functionalities involves both oxidation and condensation reactions. [4] Since the reaction requires a free carbonyl group, only "reducing sugars" participate.
The Amadori rearrangement is an organic reaction describing the acid or base catalyzed isomerization or rearrangement reaction of the N-glycoside of an aldose or the glycosylamine to the corresponding 1-amino-1-deoxy-ketose. [1]
Pigment Yellow 97, a popular yellow colorant, is a hydrazone. [6]Hydrazones are the basis for various analyses of ketones and aldehydes. For example, dinitrophenylhydrazine coated onto a silica sorbent is the basis of an adsorption cartridge.
Posturography is the technique used to quantify postural control in upright stance in either static or dynamic conditions. Among them, Computerized dynamic posturography (CDP), also called test of balance (TOB), is a non-invasive specialized clinical assessment technique used to quantify the central nervous system adaptive mechanisms (sensory, motor and central) involved in the control of ...
SCPI was defined as an additional layer on top of the IEEE 488.2-1987 specification "Standard Codes, Formats, Protocols, and Common Commands". [4] The standard specifies a common syntax, command structure, and data formats, to be used with all instruments.
Gunner G1 Kennel This durable dog kennel is perfect for travelling and has a five-star crash test rating from the Center for Pet Safety. Our tester, Lindsey, says: "My dog loved it, there is lots ...
The term "IMViC" is an acronym for each of these tests. "I" is for indole test; "M" is for methyl red test; "V" is for Voges-Proskauer test, and "C" is for citrate test. The lower case "i" is merely for "in" as the Citrate test requires coliform samples to be placed "in Citrate". These tests are useful in distinguishing members of ...
SHIRPA is an acronym of SmithKline Beecham, Harwell, Imperial College, Royal London Hospital, phenotype assessment), proposed in 1997 by a group of researchers from a number of British institutions and the pharmaceutical company, SmithKline Beecham.